Islam, keep an eye on PROTEUS DIGITAL HEALTH... they have things on the market like this; ONE: Digital Health Feedback System: Our digital health feedback system is powered by you. It includes wearable and ingestible sensors that work together to gather information about medication-taking, activity and rest patterns. By capturing objective information and providing actionable insights, you can take control, communicate with caregivers and clinicians, and stay well. How The Platform Works: The ingestible sensor is technology you swallow. It’s made entirely of ingredients found in food and activated upon ingestion. You take it alongside your medications, capturing the exact time of ingestion. Your body powers the ingestible sensor. With no battery and no antenna, your stomach fluids complete the power source and your body transmits the unique number generated by the sensor. The patch, body-worn and disposable, captures and relays your body’s physiologic responses and behaviors. It receives information from the ingestible sensor, detects heart rate, activity, and rest, and sends information to your mobile device. Using a Bluetooth-enabled device – like the one you already carry in your pocket or purse – you can access secure applications that display your data in context and support care in a variety of different ways... TWO: Proteus picks UK for smart pill production and testing: (Reuters) - A U.S. biotech company pioneering tablets containing edible embedded microchips that can tell if patients have taken their medication is to establish its first international manufacturing site in Britain. Privately held Proteus Digital Health, which is working with drugmakers including Novartis and Otsuka, said on Monday the new site would employ some 200 skilled staff and serve as a hub for the emerging digital medicine industry. The move was welcomed by Prime Minister David Cameron, who said it showed Britains ability to attract high-tech companies. Proteus already has European and U.S. approval for its smart pill technology system, in which a tiny sensor is embedded in a tablet and linked to a patch worn on the patients abdomen. About the size of a grain of sand, the sensor has no battery or antenna and is powered by reacting with stomach juices. Information is sent from the sensor to the small skin patch, which transmits data by Bluetooth to a smartphone or tablet computer. In addition to telling doctors if patients are taking their medicines properly, the tiny sensors can also monitor vital signs, such as heart rate. Several teams within Britains state-run National Health Service plan to test the benefits of using the sensor technology in various fields, including in treating hypertension, or high blood pressure. Ensuring that patients with high blood pressure, who suffer no symptoms, have taken their medicines properly is a major challenge for doctors. In May, Redwood City, California-based Proteus announced a $62.5 million funding round, including investment from new investor Oracle. (Editing by Louise Heavens). 3. Intorducing Helius; Support care delivery throughout the treatment cycle; Clinicians, patients and families can use the real-time information about medication-taking, rest and activity to make informed treatment decisions. This helps people stay on track with their daily care and keeps healthcare costs under control. Helius helps people throughout their treatment journey: 1. At the doctor’s: Helius can optimize a patient’s care by providing their doctor unprecedented insight into medication-taking patterns and how the body is responding to therapy. 2. Going home: Helius helps people successfully manage the transition to home, alerting doctors when someone needs a little extra support. 3. At home: When people are working to manage daily care, Helius ensures they stay connected with their families and on-track each day, 4. Digital Medicines; Shifting the Care Paradigm; Proteus Digital Health is working to create a new category of products and services with the potential to significantly improve the effectiveness of existing pharmaceutical treatments. We call the category Digital Medicines. Digital Medicines will be the same pharmaceuticals you take today, with one small change: each pill will also contain a tiny sensor that can communicate, via our digital health feedback system, vital information about your medication-taking behaviors and how your body is responding. In partnership with companies including Otsuka Pharmaceutical and Novartis, we are furthering the development and future commercialization of Digital Medicines. We believe this will help people throughout the healthcare spectrum:....
Posted on: Wed, 22 Oct 2014 08:10:14 +0000
Trending Topics
Recently Viewed Topics
© 2015